WithdrawnNot Applicable

B-Cell Hematologic Malignancy Vaccination Registry

Stopped: No patients enrolled

United States0Started 2014-08

Plain-language summary

The goal of this study is to develop a vaccination registry system for Aurora Health Care patients newly diagnosed with MM and other B-Cell Hematologic Malignancies in order to prospectively characterize vaccination history and outcomes such as infection in these patients at Aurora Health Care. Additionally hospitalization rates, cost analysis, infection (influenza, pneumonia, other) related to vaccination in this patient population will be evaluated.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients at Aurora Health Care who are newly diagnosed with: * Monoclonal gammopathy of undetermined significance (MGUS), * Smoldering multiple myeloma (SMM), * Multiple myeloma (MM), * Waldenstroms Macroglobulinemia (WM), * Monoclonal B-cell lymphocytosis (MBL), * Chronic lymphocytic leukemia (CLL), or * B-Cell Non-Hodgkin lymphoma (NHL). Exclusion Criteria: * none

What they're measuring

vaccination history

Timeframe: 10 years

Trial details

NCT IDNCT02298816

SponsorWake Forest University Health Sciences

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12

View on ClinicalTrials.gov More Monoclonal Gammopathy of Undetermined Significance trials